COVID-19, FDA and Vaccine
Digest more
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,
See what infectious disease doctors have to say as government officials appear poised to scale back COVID vaccines and the FDA approved the Novavax vaccine with new limitations.
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new commissioner described as a “one-size-fits-all regulatory framework.”
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use.
Secretary Kennedy's appointment led to fears that vaccine availability would be curtailed. Those fears are now being realized.